---
title: What Actually Happens in a Pre-Submission Meeting with FDA? Part II
description: We understand a lot goes into getting an application from submission to approval. We are here to help you and your team be well-informed to gather all the necessary materials before pre-submission.
image: https://blog.scalehealth.com/hubfs/Hero-074.png
---
[](https://www.sierralabs.com/)
- Products
- [Sierra Policies & Procedures](https://www.sierralabs.com/policies-procedures)
- [Sierra Document Automation](https://www.sierralabs.com/document-automation)
- [Sierra Quality Management](https://www.sierralabs.com/quality-management)
- [Sierra GxP Cloud Validation](https://www.sierralabs.com/cloud-validation)
- [Services](https://www.sierralabs.com/services)
- [About Us](https://www.sierralabs.com/about)
- [Partner](https://campaign.sierralabs.com/partner-with-sierra-labs)
- [Blog](https://blog.scalehealth.com)
- [Contact Us](https://www.sierralabs.com/document-automation/#contact-us)
[Contact Us](https://www.sierralabs.com/document-automation/#contact-us)
## Sierra Labs Blog
This is a search field with an auto-suggest feature attached.
- There are no suggestions because the search field is empty.
# What Actually Happens in a Pre-Submission Meeting with FDA? Part II
Posted by [Sierra Labs](https://blog.scalehealth.com/author/sierra-labs) on Oct 13, 2022 12:53:58 PM
- [Tweet](https://twitter.com/share)
How to get the most out of Pre-Submission meetings with the FDA.
Now that you have a better overview of a [pre-submission](https://blog.scalehealth.com/what-actually-happens-in-a-pre-submission-meeting-with-fda-part-1), your team is aware of the benefits this tool can have for launching your device(s). It is crucial to also understand what actually happens during the application process before utilizing it. We understand a lot goes into getting an application from submission to approval. We are here to help you and your team be well-informed to gather all the necessary materials before pre-submission.
**How to submit an application?**
At the time of submitting your application, your team must decide if it makes sense to meet in person, teleconference, or give written feedback. When scheduling an in-person meeting, be sure to provide them with a draft agenda and three available times to give them flexibility for the meeting.
**What is the Pre-Submission Review Workflow like?**
After submitting an application using the FDA’s acceptance checklist, the agency will have 15 days to send you a response, known as the acceptance review stage. If denied for any reason(s), your team is notified with descriptive feedback detailing why their application was rejected.
If the FDA decides to proceed with your application, you should receive written feedback from the review group within 70 days or at least 5 days before when a meeting is requested along with your feedback. Below is the expected stages of a pre-submission process:
**What are the potential types of feedback?**
The pre-submission meeting is designed to expedite the regulatory process for innovative medical technologies helping shorten total review times and make it easier on all stakeholders involved. The feedback given by the review team of the agency can include questions as specific as device classification. The following is a list of types of feedback according to the FDA:
- Device classification questions
- Intended use:
- Planned nonclinical studies:
- Planned clinical studies:
- Reference method and/or method comparison
- Statistical analyses
- Software/Cybersecurity/Risk management
- Labeling
**What not to do before or during a meeting?**
It's important that your team be as specific and clear about your questions before submitting them. Vague or general questions will not yield valuable feedback from the review group. Companies that want to avoid missing any important information during the application process should make sure they ask targeted questions in their application. General questions will only lead to addressing general areas of interest which will result in a longer timeframe for your regulatory journey.
The review team is here to answer all of your regulatory questions but they will not serve as consultants, in other words, they will not discuss specific data with you. Your team should not expect your solution to be right away approved or cleared in any way, however, you can still establish a working partnership with the FDA around your device’s regulatory journey.
**What to do after the meeting?**
Your team is responsible for drafting minutes or documenting your interactions to ensure a thorough understanding of all regulatory requirements and standards for your device. After the meeting concludes, you have 15 days to submit these minutes back to the agency. The FDA will alert you within 30 days if these draft minutes are final or if they require revisions.
You may disagree with their decisions so there is a timeline your team must follow in order to resolve any disputes. You may ask for amendments or edits of minutes within these 15 days of your meeting. If there aren’t any revisions, we still recommend you review the minutes with your team as the FDA will make these minutes final within 30 days of receiving an email.
There aren't any hard limits on the number of pre-submission meetings you can request for a specific device. If additional questions and topics arise after written feedback is given and minutes are final, then it is beneficial to apply again with your team’s new findings in mind before proceeding into a final regulatory submission.
**Simplifying Pre-submission for your team**
When submitting a request for medical devices, it is best if you find professionals who can not only help with the process but also plan out your roadmap and assemble all of the correct documentation.
When it comes to navigating the complex world of regulations, there are tools that can make this process easy and stress-free. One such resource is an electronic Quality Management System (QMS), which will help you reach your market goals with minimal worry while maximizing efficiency.
Sierra QMS is designed for organizations that are looking to market SaMDs/ DTx’s/ AIaMD in a globally regulated environment. Its incredible integration capabilities are built for engineering teams to operate with their preferred tool sets while automating the compliance process with SaMD QMS principles for global markets
**Want to see how Sierra QMS can help your organization?**
**Click Here for a Free Consultation!**
[](https://hubspot-cta-redirect-na2-prod.s3.amazonaws.com/cta/redirect/5229980/c50f501f-9ed9-4082-ba45-a69bd091b9f8)
Ask us anything.
Topics: [FDA Pre-Sub](https://blog.scalehealth.com/tag/fda-pre-sub), [Pre-Submission](https://blog.scalehealth.com/tag/pre-submission), [Regulatory Roadmap](https://blog.scalehealth.com/tag/regulatory-roadmap), [Regulatory Approach](https://blog.scalehealth.com/tag/regulatory-approach), [Pre-market approval](https://blog.scalehealth.com/tag/pre-market-approval), [DTx](https://blog.scalehealth.com/tag/dtx)
## Featured posts
### Topics
- [FDA (42)](https://blog.scalehealth.com/tag/fda)
- [QMS (31)](https://blog.scalehealth.com/tag/qms)
- [Compliance (28)](https://blog.scalehealth.com/tag/compliance)
- [Medical Device (27)](https://blog.scalehealth.com/tag/medical-device)
- [Medical Device Company (26)](https://blog.scalehealth.com/tag/medical-device-company)
- [SaMD (26)](https://blog.scalehealth.com/tag/samd)
- [Data Security (17)](https://blog.scalehealth.com/tag/data-security)
- [Regulations (17)](https://blog.scalehealth.com/tag/regulations)
- [21 CFR Part 820 (15)](https://blog.scalehealth.com/tag/21-cfr-part-820)
- [Medical Devices (15)](https://blog.scalehealth.com/tag/medical-devices)
- [ISO (14)](https://blog.scalehealth.com/tag/iso)
- [FDA Approval (13)](https://blog.scalehealth.com/tag/fda-approval)
- [Agile (12)](https://blog.scalehealth.com/tag/agile)
- [Data Privacy (12)](https://blog.scalehealth.com/tag/data-privacy)
- [FDA Regulation (12)](https://blog.scalehealth.com/tag/fda-regulation)
- [ISO 13485 (11)](https://blog.scalehealth.com/tag/iso-13485)
- [SaMD Development (11)](https://blog.scalehealth.com/tag/samd-development)
- [CFR Part 820 (10)](https://blog.scalehealth.com/tag/cfr-part-820)
- [Data Requirements (10)](https://blog.scalehealth.com/tag/data-requirements)
- [Document Controls (10)](https://blog.scalehealth.com/tag/document-controls)
- [FDA Pre-Sub (10)](https://blog.scalehealth.com/tag/fda-pre-sub)
- [Health Technology (10)](https://blog.scalehealth.com/tag/health-technology)
- [Regulatory Pathway (10)](https://blog.scalehealth.com/tag/regulatory-pathway)
- [AI (9)](https://blog.scalehealth.com/tag/ai)
- [Documentation (9)](https://blog.scalehealth.com/tag/documentation)
- [GxP Cloud (9)](https://blog.scalehealth.com/tag/gxp-cloud)
- [Quality System Regulation (9)](https://blog.scalehealth.com/tag/quality-system-regulation)
- [Technology (9)](https://blog.scalehealth.com/tag/technology)
- [Validated Cloud (9)](https://blog.scalehealth.com/tag/validated-cloud)
- [risk (9)](https://blog.scalehealth.com/tag/risk)
- [Cloud (8)](https://blog.scalehealth.com/tag/cloud)
- [FDA Audit (8)](https://blog.scalehealth.com/tag/fda-audit)
- [GxP (8)](https://blog.scalehealth.com/tag/gxp)
- [Health Data (8)](https://blog.scalehealth.com/tag/health-data)
- [ISO 13485:2016 (8)](https://blog.scalehealth.com/tag/iso-134852016)
- [ISO 14971 (8)](https://blog.scalehealth.com/tag/iso-14971)
- [Manufacturing (8)](https://blog.scalehealth.com/tag/manufacturing)
- [PHI (8)](https://blog.scalehealth.com/tag/phi)
- [Personal Health Information (8)](https://blog.scalehealth.com/tag/personal-health-information)
- [Conformity (7)](https://blog.scalehealth.com/tag/conformity)
- [Healthcare (7)](https://blog.scalehealth.com/tag/healthcare)
- [Life Science QMS (7)](https://blog.scalehealth.com/tag/life-science-qms)
- [Medical Solutions (7)](https://blog.scalehealth.com/tag/medical-solutions)
- [Product Development (7)](https://blog.scalehealth.com/tag/product-development)
- [Regulatory Strategy (7)](https://blog.scalehealth.com/tag/regulatory-strategy)
- [SaMD QMS (7)](https://blog.scalehealth.com/tag/samd-qms)
- [Software Requirement Specification (7)](https://blog.scalehealth.com/tag/software-requirement-specification)
- [Standards (7)](https://blog.scalehealth.com/tag/standards)
- [21 CFR (6)](https://blog.scalehealth.com/tag/21-cfr)
- [Quality Management System (6)](https://blog.scalehealth.com/tag/quality-management-system)
- [Quality Processes (6)](https://blog.scalehealth.com/tag/quality-processes)
- [Regulatory Roadmap (6)](https://blog.scalehealth.com/tag/regulatory-roadmap)
- [eHealth (6)](https://blog.scalehealth.com/tag/ehealth)
- [21 CFR Part 11 (5)](https://blog.scalehealth.com/tag/21-cfr-part-11)
- [Artificial Intelligence (5)](https://blog.scalehealth.com/tag/artificial-intelligence)
- [CAPA (5)](https://blog.scalehealth.com/tag/capa)
- [COVID19 (5)](https://blog.scalehealth.com/tag/covid19)
- [Design Controls (5)](https://blog.scalehealth.com/tag/design-controls)
- [Digital Health (5)](https://blog.scalehealth.com/tag/digital-health)
- [Health Tech (5)](https://blog.scalehealth.com/tag/health-tech)
- [Jira Cloud (5)](https://blog.scalehealth.com/tag/jira-cloud)
- [Jira QMS (5)](https://blog.scalehealth.com/tag/jira-qms)
- [New Drugs (5)](https://blog.scalehealth.com/tag/new-drugs)
- [QMS healthcare (5)](https://blog.scalehealth.com/tag/qms-healthcare)
- [Sierra QMS (5)](https://blog.scalehealth.com/tag/sierra-qms)
- [training management (5)](https://blog.scalehealth.com/tag/training-management)
- [Automation (4)](https://blog.scalehealth.com/tag/automation)
- [Biopharma (4)](https://blog.scalehealth.com/tag/biopharma)
- [Business Associates (4)](https://blog.scalehealth.com/tag/business-associates)
- [Communication (4)](https://blog.scalehealth.com/tag/communication)
- [Covered Entities (4)](https://blog.scalehealth.com/tag/covered-entities)
- [Data Integrity (4)](https://blog.scalehealth.com/tag/data-integrity)
- [Development Change (4)](https://blog.scalehealth.com/tag/development-change)
- [Drug Approval (4)](https://blog.scalehealth.com/tag/drug-approval)
- [GAMP5 (4)](https://blog.scalehealth.com/tag/gamp5)
- [HIPAA (4)](https://blog.scalehealth.com/tag/hipaa)
- [HIPAA Compliance (4)](https://blog.scalehealth.com/tag/hipaa-compliance)
- [Health Applications (4)](https://blog.scalehealth.com/tag/health-applications)
- [Integrated QMS (4)](https://blog.scalehealth.com/tag/integrated-qms)
- [Medical Device Startups (4)](https://blog.scalehealth.com/tag/medical-device-startups)
- [Pre-Submission (4)](https://blog.scalehealth.com/tag/pre-submission)
- [Product Lifecycle (4)](https://blog.scalehealth.com/tag/product-lifecycle)
- [Quality Roadmap (4)](https://blog.scalehealth.com/tag/quality-roadmap)
- [Recall (4)](https://blog.scalehealth.com/tag/recall)
- [Regulatory Approach (4)](https://blog.scalehealth.com/tag/regulatory-approach)
- [Remote Work (4)](https://blog.scalehealth.com/tag/remote-work)
- [Scale-ups (4)](https://blog.scalehealth.com/tag/scale-ups)
- [Software (4)](https://blog.scalehealth.com/tag/software)
- [Streamline Workflows (4)](https://blog.scalehealth.com/tag/streamline-workflows)
- [document management (4)](https://blog.scalehealth.com/tag/document-management)
- [ePHI (4)](https://blog.scalehealth.com/tag/ephi)
- [510(k) (3)](https://blog.scalehealth.com/tag/510k)
- [COVID-19 Solution (3)](https://blog.scalehealth.com/tag/covid-19-solution)
- [Case Study (3)](https://blog.scalehealth.com/tag/case-study)
- [Compliance Process (3)](https://blog.scalehealth.com/tag/compliance-process)
- [Cybersecurity (3)](https://blog.scalehealth.com/tag/cybersecurity)
- [DTx (3)](https://blog.scalehealth.com/tag/dtx)
- [Design Verification (3)](https://blog.scalehealth.com/tag/design-verification)
- [Document Automation Tools (3)](https://blog.scalehealth.com/tag/document-automation-tools)
- [FDA Standard (3)](https://blog.scalehealth.com/tag/fda-standard)
- [GAMP (3)](https://blog.scalehealth.com/tag/gamp)
- [HIPAA Checklist (3)](https://blog.scalehealth.com/tag/hipaa-checklist)
- [Hardware-based (3)](https://blog.scalehealth.com/tag/hardware-based)
- [IEC 62304 (3)](https://blog.scalehealth.com/tag/iec-62304)
- [ISPE (3)](https://blog.scalehealth.com/tag/ispe)
- [Iterative Process (3)](https://blog.scalehealth.com/tag/iterative-process)
- [Life Science (3)](https://blog.scalehealth.com/tag/life-science)
- [Medical Technology (3)](https://blog.scalehealth.com/tag/medical-technology)
- [Pharma (3)](https://blog.scalehealth.com/tag/pharma)
- [Predicate Device (3)](https://blog.scalehealth.com/tag/predicate-device)
- [Product Requirements Document (3)](https://blog.scalehealth.com/tag/product-requirements-document)
- [QMS for SaMD Startups (3)](https://blog.scalehealth.com/tag/qms-for-samd-startups)
- [Risk Management (3)](https://blog.scalehealth.com/tag/risk-management)
- [SOC (3)](https://blog.scalehealth.com/tag/soc)
- [SOC 2 (3)](https://blog.scalehealth.com/tag/soc-2)
- [SOP (3)](https://blog.scalehealth.com/tag/sop)
- [SaMD Startups (3)](https://blog.scalehealth.com/tag/samd-startups)
- [Software Development (3)](https://blog.scalehealth.com/tag/software-development)
- [Telecare (3)](https://blog.scalehealth.com/tag/telecare)
- [Telehealth (3)](https://blog.scalehealth.com/tag/telehealth)
- [eQMS (3)](https://blog.scalehealth.com/tag/eqms)
- [AWS (2)](https://blog.scalehealth.com/tag/aws)
- [Audit Trails (2)](https://blog.scalehealth.com/tag/audit-trails)
- [CDER (2)](https://blog.scalehealth.com/tag/cder)
- [CE Marking (2)](https://blog.scalehealth.com/tag/ce-marking)
- [CFR (2)](https://blog.scalehealth.com/tag/cfr)
- [Center for Biologics Evaluation and Research (2)](https://blog.scalehealth.com/tag/center-for-biologics-evaluation-and-research)
- [Center for Drug Evaluation and Research (2)](https://blog.scalehealth.com/tag/center-for-drug-evaluation-and-research)
- [Clinical Evaluation (2)](https://blog.scalehealth.com/tag/clinical-evaluation)
- [Corrective Action Preventive Action (2)](https://blog.scalehealth.com/tag/corrective-action-preventive-action)
- [Document Automation (2)](https://blog.scalehealth.com/tag/document-automation)
- [Document Control (2)](https://blog.scalehealth.com/tag/document-control)
- [Documentation Automation (2)](https://blog.scalehealth.com/tag/documentation-automation)
- [Electronic Records (2)](https://blog.scalehealth.com/tag/electronic-records)
- [GMP (2)](https://blog.scalehealth.com/tag/gmp)
- [General Controls (2)](https://blog.scalehealth.com/tag/general-controls)
- [HITRUST (2)](https://blog.scalehealth.com/tag/hitrust)
- [HITRUST CSF (2)](https://blog.scalehealth.com/tag/hitrust-csf)
- [ML (2)](https://blog.scalehealth.com/tag/ml)
- [Machine Learning (2)](https://blog.scalehealth.com/tag/machine-learning)
- [New Draft (2)](https://blog.scalehealth.com/tag/new-draft)
- [Pharmaceutical (2)](https://blog.scalehealth.com/tag/pharmaceutical)
- [Pre-market approval (2)](https://blog.scalehealth.com/tag/pre-market-approval)
- [QS (2)](https://blog.scalehealth.com/tag/qs)
- [Risk Classification (2)](https://blog.scalehealth.com/tag/risk-classification)
- [Risk Managment (2)](https://blog.scalehealth.com/tag/risk-managment)
- [Sierra Policies (2)](https://blog.scalehealth.com/tag/sierra-policies)
- [Sierra Services (2)](https://blog.scalehealth.com/tag/sierra-services)
- [Standard Operating Procedure (2)](https://blog.scalehealth.com/tag/standard-operating-procedure)
- [fda submission (2)](https://blog.scalehealth.com/tag/fda-submission)
- [mHealth Wearables (2)](https://blog.scalehealth.com/tag/mhealth-wearables)
- [rta (2)](https://blog.scalehealth.com/tag/rta)
- [software as medical device (2)](https://blog.scalehealth.com/tag/software-as-medical-device)
- [21 cfr 807 (1)](https://blog.scalehealth.com/tag/21-cfr-807)
- [513G (1)](https://blog.scalehealth.com/tag/513g)
- [AAMI TIR45 (1)](https://blog.scalehealth.com/tag/aami-tir45)
- [AICPA (1)](https://blog.scalehealth.com/tag/aicpa)
- [ANVISA (1)](https://blog.scalehealth.com/tag/anvisa)
- [Agência Nacional de Vigilância Sanitária (1)](https://blog.scalehealth.com/tag/agência-nacional-de-vigilância-sanitária)
- [Amazon Web Services (1)](https://blog.scalehealth.com/tag/amazon-web-services)
- [Analytical Validation (1)](https://blog.scalehealth.com/tag/analytical-validation)
- [Annex 11 (1)](https://blog.scalehealth.com/tag/annex-11)
- [Australian Therapeutic Goods Administration (1)](https://blog.scalehealth.com/tag/australian-therapeutic-goods-administration)
- [BLA (1)](https://blog.scalehealth.com/tag/bla)
- [Backlog (1)](https://blog.scalehealth.com/tag/backlog)
- [Biologic Approval (1)](https://blog.scalehealth.com/tag/biologic-approval)
- [Business Goals (1)](https://blog.scalehealth.com/tag/business-goals)
- [CGMP (1)](https://blog.scalehealth.com/tag/cgmp)
- [Cannabis (1)](https://blog.scalehealth.com/tag/cannabis)
- [Cannabis Compliance (1)](https://blog.scalehealth.com/tag/cannabis-compliance)
- [Change Control (1)](https://blog.scalehealth.com/tag/change-control)
- [Client Reference (1)](https://blog.scalehealth.com/tag/client-reference)
- [Clinical Development (1)](https://blog.scalehealth.com/tag/clinical-development)
- [Clinical Validation (1)](https://blog.scalehealth.com/tag/clinical-validation)
- [Code Reviews (1)](https://blog.scalehealth.com/tag/code-reviews)
- [Conference (1)](https://blog.scalehealth.com/tag/conference)
- [Coronavirus (1)](https://blog.scalehealth.com/tag/coronavirus)
- [Current Good Manufacturing Practice (1)](https://blog.scalehealth.com/tag/current-good-manufacturing-practice)
- [Customer Complaint (1)](https://blog.scalehealth.com/tag/customer-complaint)
- [Data Transfer (1)](https://blog.scalehealth.com/tag/data-transfer)
- [Design Changes (1)](https://blog.scalehealth.com/tag/design-changes)
- [Design History File (1)](https://blog.scalehealth.com/tag/design-history-file)
- [Design Transfer (1)](https://blog.scalehealth.com/tag/design-transfer)
- [Development Team (1)](https://blog.scalehealth.com/tag/development-team)
- [Device Classification (1)](https://blog.scalehealth.com/tag/device-classification)
- [Device Software Functions (1)](https://blog.scalehealth.com/tag/device-software-functions)
- [Document Publishing (1)](https://blog.scalehealth.com/tag/document-publishing)
- [Drug Manufacturing (1)](https://blog.scalehealth.com/tag/drug-manufacturing)
- [EUA (1)](https://blog.scalehealth.com/tag/eua)
- [Electronic Signatures (1)](https://blog.scalehealth.com/tag/electronic-signatures)
- [Emergency Use Authorization (1)](https://blog.scalehealth.com/tag/emergency-use-authorization)
- [Enforcement Discretion (1)](https://blog.scalehealth.com/tag/enforcement-discretion)
- [Engineering (1)](https://blog.scalehealth.com/tag/engineering)
- [Ethos Automated System (1)](https://blog.scalehealth.com/tag/ethos-automated-system)
- [FDA Draft (1)](https://blog.scalehealth.com/tag/fda-draft)
- [HHS (1)](https://blog.scalehealth.com/tag/hhs)
- [Hand Sanitizer (1)](https://blog.scalehealth.com/tag/hand-sanitizer)
- [Hardware Development (1)](https://blog.scalehealth.com/tag/hardware-development)
- [IEC (1)](https://blog.scalehealth.com/tag/iec)
- [IEC 60601 (1)](https://blog.scalehealth.com/tag/iec-60601)
- [IEC 60601:1 (1)](https://blog.scalehealth.com/tag/iec-606011)
- [IEC 62366 (1)](https://blog.scalehealth.com/tag/iec-62366)
- [IFU (1)](https://blog.scalehealth.com/tag/ifu)
- [IND (1)](https://blog.scalehealth.com/tag/ind)
- [ISO 13485: 2003 (1)](https://blog.scalehealth.com/tag/iso-13485-2003)
- [ISO90003:2004 (1)](https://blog.scalehealth.com/tag/iso900032004)
- [Intellectual Property (1)](https://blog.scalehealth.com/tag/intellectual-property)
- [International Electrotechnical Commission (1)](https://blog.scalehealth.com/tag/international-electrotechnical-commission)
- [International Organization for Standardization (1)](https://blog.scalehealth.com/tag/international-organization-for-standardization)
- [Jira Server (1)](https://blog.scalehealth.com/tag/jira-server)
- [Key Terms (1)](https://blog.scalehealth.com/tag/key-terms)
- [Labeling (1)](https://blog.scalehealth.com/tag/labeling)
- [Liability (1)](https://blog.scalehealth.com/tag/liability)
- [MDSAP (1)](https://blog.scalehealth.com/tag/mdsap)
- [METRC (1)](https://blog.scalehealth.com/tag/metrc)
- [MHLW/PMDA (1)](https://blog.scalehealth.com/tag/mhlw-pmda)
- [Management Controls (1)](https://blog.scalehealth.com/tag/management-controls)
- [Masks (1)](https://blog.scalehealth.com/tag/masks)
- [Medical Device Single Audit Program (1)](https://blog.scalehealth.com/tag/medical-device-single-audit-program)
- [Medical Marijuana (1)](https://blog.scalehealth.com/tag/medical-marijuana)
- [Ministry of Health, Labour and Welfare (1)](https://blog.scalehealth.com/tag/ministry-of-health-labour-and-welfare)
- [Myths (1)](https://blog.scalehealth.com/tag/myths)
- [New Approach Directives (1)](https://blog.scalehealth.com/tag/new-approach-directives)
- [New Drug Application (1)](https://blog.scalehealth.com/tag/new-drug-application)
- [Nonconformity (1)](https://blog.scalehealth.com/tag/nonconformity)
- [PCCP (1)](https://blog.scalehealth.com/tag/pccp)
- [PRD (1)](https://blog.scalehealth.com/tag/prd)
- [Pandemic (1)](https://blog.scalehealth.com/tag/pandemic)
- [Part 11 (1)](https://blog.scalehealth.com/tag/part-11)
- [Part 820.30 (1)](https://blog.scalehealth.com/tag/part-820-30)
- [Performance Tests (1)](https://blog.scalehealth.com/tag/performance-tests)
- [Preliminary Screening (1)](https://blog.scalehealth.com/tag/preliminary-screening)
- [Project Deliverables (1)](https://blog.scalehealth.com/tag/project-deliverables)
- [Project Timeline (1)](https://blog.scalehealth.com/tag/project-timeline)
- [QA/RA (1)](https://blog.scalehealth.com/tag/qa-ra)
- [QMSR (1)](https://blog.scalehealth.com/tag/qmsr)
- [Regulatory Options (1)](https://blog.scalehealth.com/tag/regulatory-options)
- [SRS (1)](https://blog.scalehealth.com/tag/srs)
- [SaMD Risk Classification (1)](https://blog.scalehealth.com/tag/samd-risk-classification)
- [SaMD for QMS (1)](https://blog.scalehealth.com/tag/samd-for-qms)
- [SiMD (1)](https://blog.scalehealth.com/tag/simd)
- [Software Architecture (1)](https://blog.scalehealth.com/tag/software-architecture)
- [Sprints (1)](https://blog.scalehealth.com/tag/sprints)
- [Substantial Equivalence (1)](https://blog.scalehealth.com/tag/substantial-equivalence)
- [TGA (1)](https://blog.scalehealth.com/tag/tga)
- [TSC (1)](https://blog.scalehealth.com/tag/tsc)
- [Trust Services Criteria (1)](https://blog.scalehealth.com/tag/trust-services-criteria)
- [Valid Clinical Association (1)](https://blog.scalehealth.com/tag/valid-clinical-association)
- [Validation Testing (1)](https://blog.scalehealth.com/tag/validation-testing)
- [Waterfall Method (1)](https://blog.scalehealth.com/tag/waterfall-method)
- [Webinar (1)](https://blog.scalehealth.com/tag/webinar)
- [Workflow Transitions (1)](https://blog.scalehealth.com/tag/workflow-transitions)
- [abbreviated 510(k) (1)](https://blog.scalehealth.com/tag/abbreviated-510k)
- [administrative evaluation (1)](https://blog.scalehealth.com/tag/administrative-evaluation)
- [medical device quality management system (1)](https://blog.scalehealth.com/tag/medical-device-quality-management-system)
- [paperless quality processes (1)](https://blog.scalehealth.com/tag/paperless-quality-processes)
- [qms Samd (1)](https://blog.scalehealth.com/tag/qms-samd)
- [qms cloud (1)](https://blog.scalehealth.com/tag/qms-cloud)
- [refuse-to-accept (1)](https://blog.scalehealth.com/tag/refuse-to-accept)
- [rta letter (1)](https://blog.scalehealth.com/tag/rta-letter)
- [special 510(k) (1)](https://blog.scalehealth.com/tag/special-510k)
- [traditional 510(k) (1)](https://blog.scalehealth.com/tag/traditional-510k)
See all
### Subscribe Here
- 
- © 2022 Sierra Labs, Inc.
- Contact Us
- [hello@sierralabs.com](mailto:hello@sierralabs.com)
- 3415 S. Sepulveda Blvd.
Suite 1000
Los Angeles, CA 90034
- (310) 437-8010
- Products
- Company
- [About Us](https://www.sierralabs.com/about)